报价延迟最少15分钟:2025/11/27 16:18 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
368.53 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
9.74/19.56
|
|
企业价值
76.47B
|
| 资产负债 |
|
每股账面净值
9.01
|
| 现金流量 |
|
现金流量率
0.05
|
| 损益表 |
|
收益
293.96B
|
|
每股收益
1,312.30
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe. |
